[Database's development for prospective national collection of clinical data on cervical cancer: A Delphi survey identifying consensual variables].

Gynecol Obstet Fertil Senol

Department of Obstetrics and Gynecology, Nord Hospital, APHM, chemin des Bourrely, 13015 Marseille, France; Aix-Marseille University (AMU), Univ Avignon, CNRS, IRD, IMBE UMR, Marseille, France.

Published: September 2022

Introduction: Cervical cancer (CC) is associated with poor prognosis and therapeutic morbidity in young women. The impact of European recommendations for treatments and follow-up of these patients must be assessed. There is no real-time CCU tracking basis. Main objective of our study was to identify the items of the clinical and therapeutic data necessary for the constitution of a national, dynamic and prospective clinical database allowing to characterize treatments and follow-up of patients with CC in France.

Methods: An exhaustive bibliographic research was lead with the help of the ESGO recommendations. A list of qualitative and quantitative variables characterizing CC was established. These variables were assessed by a panel of national experts from the Francogyn group, using the Delphi survey. The rate of agreement was calculated for each variable.

Results: 345 variables divided into 6 sections were identified and submitted to 26 experts. 17 experts responded to the three rounds of the Delphi method. A total of 273 items were validated. The majority of experts (90 %) also gave a favorable opinion on the addition of a quality of life section in the database.

Conclusion: This is the first study identifying 273 items chosen by consensus. The items are collected in a future national gynecological database "Epigyn".

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gofs.2022.05.004DOI Listing

Publication Analysis

Top Keywords

cervical cancer
8
delphi survey
8
treatments follow-up
8
follow-up patients
8
[database's development
4
development prospective
4
national
4
prospective national
4
national collection
4
collection clinical
4

Similar Publications

Are we ready for self-sampling for cervical cancer screening? Insights from service providers and policy makers in Nepal.

PLOS Glob Public Health

January 2025

Britain Nepal Medical Trust, United Kingdom of Great Britain and Northern Ireland (UK), London, United Kingdom.

Cervical cancer is the leading cancer among women in Nepal, but the country has very low screening rate, with only 8.2% of women being screened. In recent years, a self-sampling kit for testing for the human papillomavirus (HPV) has been developed to allow self-sampling and enable early detection of cervical abnormalities.

View Article and Find Full Text PDF

Nasopharyngeal tuberculosis suspected of malignancy: A case report.

Medicine (Baltimore)

January 2025

Department of Otorhinolaryngology, Head and Neck Surgery, School of Medicine, Kyungpook National University, Kyungpook National University Chilgok Hospital, Daegu, South Korea.

Rationale: Nasopharyngeal tuberculosis (TB), a rare form of tuberculosis outside the lungs, can affect any organ or tissue in the body. It is difficult to diagnose because of nonspecific symptoms, often leading to delayed confirmation after the initial patient visit. Clinical manifestations such as cervical lymphadenopathy and irregular mucosal surfaces can be challenging to distinguish from nasopharyngeal cancer or malignant lymphoma.

View Article and Find Full Text PDF

Objective: The Enduring Consensus Cervical Cancer Screening and Management Guidelines Committee developed recommendations for the use of extended genotyping results in cervical cancer prevention programs.

Methods: Risks of cervical intraepithelial neoplasia grade 3 or worse were calculated using data obtained with the Onclarity HPV Assay from large cohorts. Management recommendations were based on clinical action thresholds developed for the 2019 American Society for Colposcopy and Cervical Pathology Risk-Based Management Consensus Guidelines.

View Article and Find Full Text PDF

Cytotoxic and antibacterial activity of naturally occurring agglutinin produced from the root of Poir.

Nat Prod Res

January 2025

Bioprocess Engineering Division, Smykon Biotech, Kanniyakumari, Tamilnadu, India.

Lectins are naturally occurring agglutinins which are produced more from plants sources compared to animal sources. The present study aims to screen the potential applications of lectin isolated from the mangrove plant, Poir. This root agglutinin of showed highest HA titre with buffalo erythrocytes.

View Article and Find Full Text PDF

Aim This study aimed to investigate women's knowledge and beliefs about cervical cancer and cervical smear examinations. Methodology The research was conducted at a health center in Greece from May 15, 2023, to August 15, 2023. The study sample consisted of 160 women aged 21-65 years who attended the health center.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!